Modeling studies on the role of vitamins B1 (thiamin), B3 (nicotinamide), B6 (pyridoxamine), and caffeine as potential leads for the drug design against COVID-19.

Journal of molecular modeling2022Aghamohammadi M, Sirouspour M, Goncalves AS, et al.

Study designOther primary literature

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Antiviral AgentsCOVID-19 Drug TreatmentCaffeineDrug DesignHumansMolecular Docking SimulationNiacinamidePandemicsPyridoxamineSARS-CoV-2ThiamineVitamins

DOI 10.1007/s00894-022-05356-9

PMID 36342543

View source →